AstraZeneca PLC (AZN)
160.17
+0.53
(+0.33%)
USD |
NYSE |
Sep 11, 16:00
156.50
-3.67
(-2.29%)
After-Hours: 20:00
AstraZeneca 1 Year Total Returns (Daily) : 0.45% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.45% |
| September 10, 2026 | 0.48% |
| September 09, 2026 | -1.72% |
| September 08, 2026 | -0.20% |
| September 04, 2026 | 1.19% |
| September 03, 2026 | 2.06% |
| September 02, 2026 | 2.52% |
| September 01, 2026 | 3.42% |
| August 31, 2026 | 3.21% |
| August 28, 2026 | 3.45% |
| August 27, 2026 | 4.69% |
| August 26, 2026 | 5.64% |
| August 25, 2026 | 8.33% |
| August 24, 2026 | 4.72% |
| August 21, 2026 | 4.92% |
| August 20, 2026 | 3.90% |
| August 19, 2026 | 5.48% |
| August 18, 2026 | 2.92% |
| August 17, 2026 | 0.79% |
| August 14, 2026 | 1.41% |
| August 13, 2026 | 2.61% |
| August 12, 2026 | 7.00% |
| August 11, 2026 | 9.01% |
| August 10, 2026 | 11.97% |
| August 07, 2026 | 10.87% |
| Date | Value |
|---|---|
| August 06, 2026 | 11.35% |
| August 05, 2026 | 10.33% |
| August 04, 2026 | 6.15% |
| August 03, 2026 | 8.69% |
| July 31, 2026 | 18.09% |
| July 30, 2026 | 13.83% |
| July 29, 2026 | 19.19% |
| July 28, 2026 | 22.18% |
| July 27, 2026 | 18.79% |
| July 24, 2026 | 16.88% |
| July 23, 2026 | 17.28% |
| July 22, 2026 | 22.53% |
| July 21, 2026 | 25.38% |
| July 20, 2026 | 21.69% |
| July 17, 2026 | 24.08% |
| July 16, 2026 | 22.91% |
| July 15, 2026 | 21.83% |
| July 14, 2026 | 16.67% |
| July 13, 2026 | 21.22% |
| July 10, 2026 | 21.59% |
| July 09, 2026 | 28.24% |
| July 08, 2026 | 37.54% |
| July 07, 2026 | 41.12% |
| July 06, 2026 | 39.32% |
| July 02, 2026 | 39.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| GSK Plc | 20.23% |
| Johnson & Johnson | 52.13% |
| Eli Lilly & Co. | 48.46% |
| Merck & Co., Inc. | 74.72% |
| Novo Nordisk A/S | -16.89% |